Endava
DAVA · NYSE
About DAVA
- Employees
- 11,385
- Headquarters
- London
- Listed
- Jul 27, 2018
- Sector
- Information Technology
- Industry
- IT Services
- Website
- endava.com
DAVA key statistics
- Market cap
- 115.23M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 778.95K
- Volume
- 439.78K
- Open price
- $2.09
- High today
- $2.25
- Low today
- $2.07
- 52 Week high
- $9.88
- 52 Week low
- $1.60
Endava (DAVA) at a glance
As of Oct 20, 2026, Endava (DAVA) shares are priced at $2.19, giving the company a market cap of 115.23M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $2.07 and $2.25. The current price is 5.8% above the day's low and 2.4% below its high.
Volume so far is 439.78K shares, below the average of 778.95K shares a day.
Over the past year Endava has ranged from $1.60 to $9.88, and now sits 7% of the way up that range.
Endava met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q1 FY26 it reported $0.0501 per share against an estimate of $0.2069.
The average analyst price target is $5.00, 128.2% above the current price, from 8 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy25.0%
- Hold50.0%
- Sell25.0%
- Low
- $2.02
- Now
- $2.19
- High
- $10.50
DAVA earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 10.1% on average.
- Q2 FY24: reported $0.30 per share against an estimate of $0.2972
- Q3 FY24: reported $0.22 per share against an estimate of $0.187
- Q4 FY24: reported $0.22 per share against an estimate of $0.2307
- Q1 FY25: reported $0.254 per share against an estimate of $0.2187
- Q2 FY25: reported $0.2997 per share against an estimate of $0.2529
- Q3 FY25: reported $0.34 per share against an estimate of $0.324
- Q4 FY25: reported $0.16 per share against an estimate of $0.1565
- Q1 FY26: reported $0.0501 per share against an estimate of $0.2069
DAVA news
- Press releaseBusiness Wire
- Press releasePRNewswire
What Does Endava plc's 24.37% Stock Drop Mean for Investors? The Law Offices of Howard G. Smith Outlines Securities Fraud Class Action Lead Plaintiff Deadline
- Press releasePRNewswire
Endava plc (DAVA) Facing Securities Class Action Amid Delayed Financials, Potential Improper Accounting, CFO On Leave
- Press releasePRNewswire
What Should Endava plc Investors Know After 24.37% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline
- Press releaseGlobe Newswire
DAVA INVESTOR ALERT: Endava plc Investors with Substantial Losses Have Opportunity to Lead the Endava Class Action Lawsuit – Hagens Berman
- Press releasePRNewswire
DAVA Investors Have Opportunity to Lead Endava plc Securities Fraud Lawsuit with SBS Law
- Press releaseNewsfile
Kaplan Fox Advises Endava plc (DAVA) Investors to Act Before the Lead Plaintiff Deadline on November 30, 2026
- Press releasePRNewswire
DAVA SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Endava plc (NASDAQ: DAVA) Investors of Securities Class Action Lawsuit Deadline on November 30, 2026
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.